Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial
Epilepsia · 2025
DOI: 10.1111/epi.18292 ↗Kurz gefasst
Äquivalenzstudie in der Zeitschrift Epilepsia, 2025. Verfasst von Vaishakh Anand und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence & Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics, All India In…. Hauptthemen laut MEDLINE: Diet, High-Protein Low-Carbohydrate, Diet, Ketogenic, Drug Resistant Epilepsy, Glycemic Index. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
The ketogenic diet has been the mainstay of treatment of drug‐resistant epilepsy (DRE). No comparative trials have been conducted to assess the efficacy of the two less strict ketogenic diets: modified Atkins diet (MAD) and low glycemic index treatment (LGIT). This study assesses the non‐inferiority of LGIT compared with MAD.
Methods
This was an open‐label randomized non‐inferiority trial. Children with DRE were randomized to receive either MAD or LGIT as an add‐on to anti‐seizure medications. The primary endpoint was percentage seizure reduction at the end of 24 weeks of therapy compared to the baseline. The non‐inferiority margin of −15% was predefined to calculate the sample size.
Results
Ninety‐one children were enrolled and randomized to receive either MAD ( n = 45) or LGIT ( n = 46). Intention‐to‐treat analysis done at the end of 24 weeks of therapy showed a mean (±standard deviation [SD]) percentage seizure reduction of 60.7% (±41.3) in the MAD sub‐group and 57% (±39.4) in the LGIT sub‐group ( p = 0.664). The absolute difference between the means of percentage seizure reduction was −3.7 (−20.5 to 13.2) and crossed the non‐inferiority margin. Ten children in the MAD group and nine children in the LGIT group did not complete 24 weeks of therapy. Adverse effects were comparable between the arms (MAD, 66.6%; LGIT, 50%), although serious adverse effects were higher in the MAD arm. The most common adverse effect was decreased acceptance (24.2%) followed by decreased satiety (9.9%), vomiting (9.9%), weight loss (5.5%), constipation (5.5%), and diarrhea (3.3%). Dyslipidemia was more commonly seen in the MAD group (MAD, six; LGIT, one). One death in the LGIT arm was unrelated to therapy. Although there was no statistically significant difference in improvement in cognition, behavior, and quality of life scales, improvement was noted from baseline scores. Significance LGIT may be non‐inferior to MAD in the treatment of children with DRE with the advantage of increased acceptance and fewer adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Excellence & Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pediatrics, Senior Dietician, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pediatrics, Armed Forces Medical College, Pune, India.
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Vaishakh Anand, Sheffali Gulati, Gautam Kamila, Aakash Mahesan, Vishal Sondhi, Biswaroop Chakrabarty, Prashant Jauhari, Prateek Kumar Panda
Förderung
- Indian Council of Medical Research
Zitieren
APA
Anand, V., Gulati, S., Agarwala, A., Kamila, G., Mahesan, A., Sondhi, V., Gupta, K. L., Chakrabarty, B., Jauhari, P., Panda, P. K., & Pandey, R. M. (2025). Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial. Epilepsia. https://doi.org/10.1111/epi.18292
Vancouver
Anand V, Gulati S, Agarwala A, Kamila G, Mahesan A, Sondhi V, et al. Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial. Epilepsia. 2025. doi:10.1111/epi.18292
BibTeX
@article{Anand2025,
author = {Anand, Vaishakh and Gulati, Sheffali and Agarwala, Anuja and Kamila, Gautam and Mahesan, Aakash and Sondhi, Vishal and Gupta, Kanak L and Chakrabarty, Biswaroop and Jauhari, Prashant and Panda, Prateek Kumar and Pandey, Ravindra Mohan},
title = {Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18292}
}
EUVIMED